The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP
Open accessAbstract
Mice with monoallelic inactivation of the CBP gene develop highly penetrant, multilineage defects in hematopoietic differentiation and, with advancing age, an increased incidence of hematologic malignancies. The latter are characterized, at least in some cases, by loss of heterozygosity (LOH) at the CBP locus. No such pathology was observed in wild-type or p300 heterozygous null mice of the same age and genetic background. Thus, a full complement of CBP, but not p300, is required for normal hematopoietic differentiation. These results also provide the first experimental evidence for the hypothesis that CBP has tumor-suppressing activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibodies, a laboratory manual
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,366
Cold Spring Harbor Laboratory; Cold Spring Harbor, NY: 1979 xxxvi + 1388 pages. $120.00
Cavalier-Smith, T. (1980) · FEBS Letters · doi:10.1016/0014-5793(80)80323-1 · Cited by 6,273
Identification of c- MYC as a Target of the APC Pathway
He, T.-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · Science · doi:10.1126/science.281.5382.1509 · Cited by 4,566
The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases
Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., & Nakatani, Y. (1996) · Cell · doi:10.1016/s0092-8674(00)82001-2 · Cited by 2,952
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
The CBP co-activator is a histone acetyltransferase
Bannister, A. J., & Kouzarides, T. (1996) · Nature · doi:10.1038/384641a0 · Cited by 1,805
A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
Yang, X.-J., Ogryzko, V. V., Nishikawa, J.-I., Howard, B. H., & Nakatani, Y. (1996) · Nature · doi:10.1038/382319a0 · Cited by 1,479
Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP
Petrif, F., Giles, R. H., Dauwerse, H. G., Saris, J. J., Hennekam, R. C. M., Masuno, M., Tommerup, N., van Ommen, G.-J. B., Goodman, R. H., Peters, D. J. M., et al. (1995) · Nature · doi:10.1038/376348a0 · Cited by 1,217
Yao, T.-P., Oh, S. P., Fuchs, M., Zhou, N.-D., Ch'ng, L.-E., Newsome, D., Bronson, R. T., Li, E., Livingston, D. M., & Eckner, R. (1998) · Cell · doi:10.1016/s0092-8674(00)81165-4 · Cited by 1,014
Self-citationThe murine gene p27Kip1 is haplo-insufficient for tumour suppression
Fero, M. L., Randel, E., Gurley, K. E., Roberts, J. M., & Kemp, C. J. (1998) · Nature · doi:10.1038/24179 · Cited by 784
Borrow, J., Stanton, V. P., Andresen, J. M., Becher, R., Behm, F. G., Chaganti, R. S. K., Civin, C. I., Disteche, C., Dubé, I., Frischauf, A. M., et al. (1996) · Nature Genetics · doi:10.1038/ng0996-33 · Cited by 771
Cellular targets for transformation by the adenovirus E1A proteins
Whyte, P., Williamson, N. M., & Harlow, E. (1989) · Cell · doi:10.1016/0092-8674(89)90984-7 · Cited by 729
RNA Helicase A Mediates Association of CBP with RNA Polymerase II
Nakajima, T., Uchida, C., Anderson, S. F., Lee, C.-G., Hurwitz, J., Parvin, J. D., & Montminy, M. (1997) · Cell · doi:10.1016/s0092-8674(00)80376-1 · Cited by 540
The p300/CBP family: integrating signals with transcription factors and chromatin
Shiama, N. (1997) · Trends in Cell Biology · doi:10.1016/s0962-8924(97)01048-9 · Cited by 487
The nuclear hormone receptor coactivator SRC-1 is a specific target of p300.
Yao, T. P., Ku, G., Zhou, N., Scully, R., & Livingston, D. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10626 · Cited by 453
Self-citationConjunction dysfunction: CBP/p300 in human disease
Giles, R. H., Peters, D. J. M., & Breuning, M. H. (1998) · Trends in Genetics · doi:10.1016/s0168-9525(98)01438-3 · Cited by 403
The molecular role of Myc in growth and transformation: recent discoveries lead to new insights
Facchini, L. M., & Penn, L. Z. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.9.633 · Cited by 377
Drosophila CBP represses the transcription factor TCF to antagonize Wingless signalling
Waltzer, L., & Bienz, M. (1998) · Nature · doi:10.1038/26785 · Cited by 362
Blobel, G. A., Nakajima, T., Eckner, R., Montminy, M., & Orkin, S. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2061 · Cited by 355
Sobulo, O. M., Borrow, J., Tomek, R., Reshmi, S., Harden, A., Schlegelberger, B., Housman, D., Doggett, N. A., Rowley, J. D., & Zeleznik-Le, N. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8732 · Cited by 319
Oike, Y. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.3.387 · Cited by 305
Tanaka, Y., Naruse, I., Maekawa, T., Masuya, H., Shiroishi, T., & Ishii, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10215 · Cited by 294
Tumors in Rubinstein‐Taybi syndrome
Miller, R. W., & Rubinstein, J. H. (1995) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320560125 · Cited by 283
p300 gene alterations in colorectal and gastric carcinomas.
Muraoka, M., Konishi, M., Kikuchi‐Yanoshita, R., Tanaka, K., Shitara, N., Chong, J., Iwama∥, T., & Miyaki, M. (1996) · PubMed · Cited by 282
Chromatin Remodeling and Leukemia: New Therapeutic Paradigms
Redner, R. L., Wang, J., & Liu, J. M. (1999) · Blood · doi:10.1182/blood.v94.2.417 · Cited by 189
Oike, Y., Takakura, N., Hata, A., Kaname, T., Akizuki, M., Yamaguchi, Y., Yasue, H., Araki, K., Yamamura, K.-I., & Suda, T. (1999) · Blood · doi:10.1182/blood.v93.9.2771 · Cited by 184
p300 and CBP as transcriptional regulators and targets of oncogenic events.
Eckner, R. (1996) · PubMed · Cited by 112
The Morphology, Immunohistochemistry, and Incidence of Hematopoietic Neoplasms in Mice and Rats
Frith, C. H., Ward, J. M., & Chandra, M. (1993) · Toxicologic Pathology · doi:10.1177/019262339302100213 · Cited by 91
Rebel, V. I., Hartnett, S., Hill, G. R., Lazo-Kallanian, S., Ferrara, J. L. M., & Sieff, C. A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1493 · Cited by 89
Self-citationEckner, R., Arany, Z. P., Ewen, M. E., Sellers, W. R., & Livingston, D. M. (1994) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1994.059.01.012 · Cited by 49
Self-citationEXPERIMENTAL PLASMACYTOMAGENESIS IN MICE
Potter, M. (1997) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70434-2 · Cited by 32
Independent transformation activity by adenovirus-5 E1A-Conserved regions 1 or 2 mutants
Svensson, C., Bondesson, M., Nyberg, E., Linder, S., Jones, N. C., & Akusjärvi, G. (1991) · Virology · doi:10.1016/0042-6822(91)90596-4 · Cited by 20
Drews, R. E., Kolker, M. T., Moran, C., Sachar, D. S., Chan, V., & Schnipper, L. E. (1998) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(98)00149-3 · Cited by 4
Cited by
Roth, S. Y., Denu, J. M., & Allis, C. D. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.81 · Cited by 1,845
CBP/p300 in cell growth, transformation, and development
Goodman, R. H., & Smolik, S. (2000) · Genes & Development · doi:10.1101/gad.14.13.1553 · Cited by 1,778
“The heart defects detected in CBP- and p300-deficient knockout mice (Yao et al. 1998; Kung et al. 2000) support the idea that these coactivators are indeed required for normal cardiac development but do not provide much insight into precisely how they mediate their effects.”
Backgroundp300/CBP proteins: HATs for transcriptional bridges and scaffolds
Chan, H. M., & La Thangue, N. B. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.13.2363 · Cited by 1,092
Can we safely target the WNT pathway?
Kahn, M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4233 · Cited by 1,034
Inactivating mutations of acetyltransferase genes in B-cell lymphoma
Pasqualucci, L., Dominguez-Sola, D., Chiarenza, A., Fabbri, G., Grunn, A., Trifonov, V., Kasper, L. H., Lerach, S., Tang, H., Ma, J., et al. (2011) · Nature · doi:10.1038/nature09730 · Cited by 949
Metadata
- Authors
- Kung, A. L., Rebel, V. I., Bronson, R. T., Ch'ng, L.-E., Sieff, C. A., Livingston, D. M., & Yao, T.-P.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2000-02-01
- Volume
- 14
- Issue
- 3
- Pages
- 272-277
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2166091854
- Cited by
- 440
- References
- 33
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.